Interferon beta-1b in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis:: results of a Markov disease model for Sweden and the UK

被引：0
|
作者：
Kobelt, G
Jönsson, L
Fredrikson, S
机构：
[1] Karolinska Inst, Stockholm, Sweden
[2] Stockholm Hlth Econ Consulting, Stockholm, Sweden
[3] Huddinge Univ Hosp, Stockholm, Sweden
来源：
JOURNAL OF NEUROLOGY | 2004年 / 251卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [1] Interferon beta-1b in relapsing-remitting multiple sclerosis: the effect of disease duration on treatment efficacy
    Rusek, S.
    Hozejowski, R.
    Tutaj, A.
    Kozlowska-Boszko, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 257 - 257
  • [2] Interferon beta-1b treatment in patients with relapsing-remitting multiple sclerosis under a standardized protocol in Spain
    Arbizu, T
    Alvarez-Cermeño, JC
    Decap, G
    Fernández, O
    Uría, DF
    Merino, AG
    Izquierdo, G
    Montalbán, X
    ACTA NEUROLOGICA SCANDINAVICA, 2000, 102 (04): : 209 - 217
  • [3] Neutralizing Antibodies during Treatment with Interferon Beta-1b in 1745 Patients with Relapsing-Remitting Multiple Sclerosis
    Goodin, Douglas
    O'Connor, Paul
    Hartung, Hans P.
    Kappos, Ludwig
    Arnason, Barry
    Comi, Giancarlo
    Cook, Stuart
    Filippi, Massimo
    Jeffery, Douglas
    Bogumil, Timon
    Sandbrink, Rupert
    Beckmann, Karola
    Boateng, Francis
    Pohl, Christoph
    NEUROLOGY, 2009, 72 (11) : A317 - A318
  • [4] Neutralizing antibodies and the efficacy of interferon beta-1b in relapsing-remitting multiple sclerosis
    Petkau, J
    White, R
    MULTIPLE SCLEROSIS, 1997, 3 (06): : 402 - 402
  • [5] Cost-utility of interferon β1b in the treatment of patients with active relapsing-remitting or secondary progressive multiple sclerosis
    G. Kobelt
    L. Jönsson
    S. Fredrikson
    The European Journal of Health Economics, 2003, 4 (1) : 50 - 59
  • [6] Interferon beta-1b for treatment of secondary progressive multiple sclerosis
    Zimmermann, C
    Walther, EU
    Goebels, N
    Lienert, C
    Kappos, L
    Hartung, HP
    Hohlfeld, R
    NERVENARZT, 1999, 70 (08): : 759 - 763
  • [7] Safety and tolerability of interferon-beta-1b in combination with tacrolimus in the treatment of relapsing-remitting and secondary progressive multiple sclerosis
    Jacques, F.
    Christie, S.
    Grand'Maison, F.
    Gaboury, I.
    Halle, D.
    Carignan, M. J.
    MULTIPLE SCLEROSIS, 2006, 12 : S213 - S213
  • [8] Spotlight on Interferon-β-1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis
    Paul L. McCormack
    Lesley J. Scott
    BioDrugs, 2004, 18 : 343 - 347
  • [9] Health economic evaluation of interferon beta-1a versus interferon beta-1b for patients with relapsing-remitting multiple sclerosis in Switzerland
    Nuijten, M. J. C.
    Chofflon, M.
    MULTIPLE SCLEROSIS, 2007, 13 : S262 - S262
  • [10] Spotlight on interferon-β-1b in relapsing-remitting and secondary progressive multiple sclerosis
    McCormack, PL
    Scott, LJ
    BIODRUGS, 2004, 18 (05) : 343 - 347
12345